Boundless Bio Inc (BOLD)
6.92
-0.57
(-7.61%)
USD |
NASDAQ |
Jun 14, 16:00
6.92
0.00 (0.00%)
After-Hours: 17:21
Boundless Bio Enterprise Value: 61.81M for June 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 13, 2024 | 61.81M |
| June 12, 2024 | 66.92M |
| June 11, 2024 | 100.31M |
| June 10, 2024 | 104.09M |
| June 07, 2024 | 109.21M |
| June 06, 2024 | 102.53M |
| June 05, 2024 | 94.52M |
| June 04, 2024 | 99.64M |
| June 03, 2024 | 97.19M |
| May 31, 2024 | 98.08M |
| May 30, 2024 | 85.40M |
| May 29, 2024 | 89.18M |
| May 28, 2024 | 108.76M |
| May 24, 2024 | 146.82M |
| May 23, 2024 | 129.24M |
| May 22, 2024 | 140.36M |
| May 21, 2024 | 139.70M |
| May 20, 2024 | 131.46M |
| May 17, 2024 | 110.32M |
| May 16, 2024 | 116.77M |
| May 15, 2024 | 107.21M |
| May 14, 2024 | 101.64M |
| May 13, 2024 | 106.98M |
| May 10, 2024 | 86.29M |
| May 09, 2024 | 97.64M |
| Date | Value |
|---|---|
| May 08, 2024 | 115.44M |
| May 07, 2024 | 117.66M |
| May 06, 2024 | 113.44M |
| May 03, 2024 | 103.06M |
| May 02, 2024 | 96.39M |
| May 01, 2024 | 117.51M |
| April 30, 2024 | 115.29M |
| April 29, 2024 | 149.98M |
| April 26, 2024 | 153.99M |
| April 25, 2024 | 163.55M |
| April 24, 2024 | 140.42M |
| April 23, 2024 | 132.19M |
| April 22, 2024 | 117.74M |
| April 19, 2024 | 119.51M |
| April 18, 2024 | 146.42M |
| April 17, 2024 | 146.20M |
| April 16, 2024 | 129.97M |
| April 15, 2024 | 135.08M |
| April 12, 2024 | 146.20M |
| April 11, 2024 | 153.76M |
| April 10, 2024 | 159.10M |
| April 09, 2024 | 161.99M |
| April 08, 2024 | 172.22M |
| April 05, 2024 | 189.12M |
| April 04, 2024 | 184.23M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
61.81M
Minimum
Jun 13 2024
198.02M
Maximum
Apr 02 2024
127.73M
Average
117.70M
Median
Enterprise Value Benchmarks
| Syra Health Corp | 6.558M |
| Adlai Nortye Ltd | -- |
| CEL-SCI Corp | 64.56M |
| AIM ImmunoTech Inc | 13.40M |
| IGC Pharma Inc | 26.23M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -15.43M |
| Total Expenses (Quarterly) | 16.88M |
| EPS Diluted (Quarterly) | -12.27 |
| Earnings Yield | -206.6% |